Delivery Order SPE2DB24D2205-SPE2DB24FDWUV

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $38,534.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 19, 2024 with an ultimate completion date of April 22, 2024. The contract has no set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $25,199.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 3, 2024. The contract does not have a set-aside designation,...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of PRIORIX Vials, a pharmaceutical product, to the government. The $3,028.26 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 9, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $24,395.00 firm-fixed-price delivery order is for the supply of PRIORIX VIALS to the agency. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $72,759.08. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 3, 2023. The contract was not designated with a set-aside,...
This federal contract award, valued at $24,271.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for PRIORIX VIALS, a medical product, with a completion date of March 3, 2025. The contract is a firm-fixed-price agreement and was not set aside for any specific business designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of PRIORIX vials, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $5,047.10 and an ultimate completion date of February 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, on a firm fixed-price basis. The contract has a ceiling value of $4,732.46 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,385.69 delivery order contract is for the supply of PRIORIX VIALS, a medical product, and has a period of performance through March 4, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $25,235.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of PRIORIX VIALS, with a completion date of June 4, 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWUV
    Delivery Order

This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $24,395.00, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and a completion date of July 15, 2024. The contract is a delivery order, and there is no set-aside designation indicated.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 9:52 AM